—
C+
C+ The full Closelooknet — membership. Open the C+ overview

GeneDx Holdings Corp. (WGS) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for WGS, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 1.92 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How WGS has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.92 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), GeneDx Holdings Corp. moved 1.92% on average · correlation 0.21 · higher than 99% of US names
  • Beta, last 3 months 1.92 about the same as over the year
  • On the 10 worst bond days −1.64% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +3.85% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Diagnostics & Research · US · 7 names with week and year-to-date

Peer group

Diagnostics & Research · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against WGS on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — GeneDx Holdings Corp.

WGS in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
GeneDx runs genetic testing services built around whole exome and whole genome sequencing, aimed mainly at diagnosing rare and paediatric disease. It also sells data and information services drawn from its sequencing work, and has built an AI-based platform that supports interpretation and clinical reporting for rare disease, hereditary risk and cancer tests. It is based in Stamford, Connecticut, and lists in the United States.
Where it sits in the stack
GeneDx carries no seat in our index; it sits in the Diagnostics & Research sleeve of our Healthcare universe, where sequencing volume and interpretation software rather than compute hardware set the pace.
Who it is priced against
Closelooknet's peer group does not name a comparison set for this stock; the name the market places alongside it is Natera, another genetic-testing company built on sequencing.
Why Closelooknet tracks it
GeneDx holds no seat in our index and carries no Closelooknet score, so the diary has not built a scored view of it and does not quote it in the editions.
What the diary watches
Whether the AI-based interpretation platform changes reporting turnaround or reimbursement for rare-disease and hereditary-risk tests, which would alter how the diary reads its sequencing volume.

GeneDx Holdings Corp. (WGS) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is GeneDx Holdings Corp. (WGS)?

GeneDx Holdings Corp. trades as WGS on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is WGS in a Closelooknet index?

Not currently — GeneDx Holdings Corp. is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does WGS trade against its moving averages?

Recovery attempt under the 200-day: Trades +10.6% vs the 50-day and +10% vs the 200-day average, 48.3% below the 52-week high and +174.4% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does GeneDx Holdings Corp. trade when bond yields rise?

Over the past year GeneDx Holdings Corp. had a beta of 1.92 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 99% of US names. On the 10 sessions in which long bonds fell most it moved −1.64% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does GeneDx Holdings Corp. do?

GeneDx runs genetic testing services built around whole exome and whole genome sequencing, aimed mainly at diagnosing rare and paediatric disease. It also sells data and information services drawn from its sequencing work, and has built an AI-based platform that supports interpretation and clinical reporting for rare disease, hereditary risk and cancer tests. It is based in Stamford, Connecticut, and lists in the United States. Closelooknet's peer group does not name a comparison set for this stock; the name the market places alongside it is Natera, another genetic-testing company built on sequencing.

Where does GeneDx Holdings Corp. sit in the AI build-out?

GeneDx carries no seat in our index; it sits in the Diagnostics & Research sleeve of our Healthcare universe, where sequencing volume and interpretation software rather than compute hardware set the pace. GeneDx holds no seat in our index and carries no Closelooknet score, so the diary has not built a scored view of it and does not quote it in the editions.

What does this page show?

A live price chart with SMA overlays and drawing tools for WGS, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.